North Rock Partners, LLC Moderna, Inc. Transaction History

North Rock Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$135.66 - $197.02 $53,450 - $77,625	-394 Reduced 18.99%	1,681 $258,000
Q4 2022 Feb 01, 2023	BUY	$118.38 - $210.04 $245,638 - $435,833	2,075 New	2,075 $372,000
Q2 2022 Aug 04, 2022	BUY	$117.13 - $176.59 $29,751 - $44,853	254 Added 16.22%	1,820 $260,000
Q1 2022 May 05, 2022	BUY	$126.46 - $235.05 $24,406 - $45,364	193 Added 14.06%	1,566 $270,000
Q4 2021 Feb 07, 2022	BUY	$225.82 - $368.51 $102,748 - $167,672	455 Added 49.56%	1,373 $349,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $203,704 - $444,743	918 New	918 $396,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on North Rock Partners, LLC with notifications on news.